Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

txt4AML: An Innovative Mobile Intervention to Improve Oral Anti-Cancer Medications Among Acute Myeloid Leukemia Patients

NCT05595135 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05595135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05595135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
txt4AML: An Innovative Mobile Intervention to Improve Oral Anti-Cancer Medications Among Acute Myeloid Leukemia Patients
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Withdrawn
Start date
August 15, 2022
Completion date
May 5, 2023
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia